Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

14-12-2018 | Systemic sclerosis | Case report | Article

A systemic sclerosis patient who has undergone autologous stem cell transplantation

Daniel Furst and Nihal Fathi present a case of a patient with diffuse systemic sclerosis who undergoes autologous hematopoietic stem cell transplantation after failing two other therapies.

10-12-2018 | Psoriatic arthritis | Highlight | News

ACR/NPF guidelines for the treatment of PsA published

The American College of Rheumatology and the National Psoriasis Foundation have issued evidence-based guidelines for the pharmacologic and nonpharmacologic treatment of active psoriatic arthritis.

29-11-2018 | Pediatric | View from the clinic | Collection

Growing up right: Transitioning from pediatric to adult rheumatology care

Sangeeta Sule outlines the challenges of transitioning from pediatric to adult rheumatology care, highlights key resources to support families and healthcare providers, and provides tips on managing the transition process.

Latest from across the site

14-12-2018 | Rheumatoid arthritis | News

Support for abatacept–methotrexate combination therapy in RA patients

Adding abatacept to methotrexate improves disease activity and reduces structural progression among ACPA-positive rheumatoid arthritis patients with early erosion, Japanese researchers report.

Source:

RMD Open 2018; 4: e000813

14-12-2018 | Systemic sclerosis | Case report | Article

A systemic sclerosis patient who has undergone autologous stem cell transplantation

Daniel Furst and Nihal Fathi present a case of a patient with diffuse systemic sclerosis who undergoes autologous hematopoietic stem cell transplantation after failing two other therapies.

Authors:
Daniel Furst, Nihal Fathi

12-12-2018 | Gout | News

Hepatotoxicity reassurance for febuxostat-treated patients with gout and fatty liver disease

Results of an observational study provide preliminary evidence suggesting that patients with gout and fatty liver disease who are treated with febuxostat do not have an elevated risk for hepatotoxicity.

Source:

J Rheumatol 2018; doi:10.3899/jrheum.180761

10-12-2018 | Psoriatic arthritis | Highlight | News

ACR/NPF guidelines for the treatment of PsA published

The American College of Rheumatology and the National Psoriasis Foundation have issued evidence-based guidelines for the pharmacologic and nonpharmacologic treatment of active psoriatic arthritis.

Source:

Arthritis Rheumatol 2018; doi:10.1002/art.40726
Arthritis Care Res 2018; doi:10.1002/acr.23789
J Psoriasis Psoriatic Arthritis 2018; doi:10.1177/2475530318812244

06-12-2018 | Rheumatoid arthritis | News

Targeting B cells may delay RA development in those at risk

B-cell directed therapy with a single infusion of rituximab significantly delays the development of rheumatoid arthritis in people at high risk for developing the condition, exploratory study data show.

Source:

Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2017-212763

04-12-2018 | Ankylosing spondylitis | News

Elevated CRP levels may point to better secukinumab response in AS patients

Ankylosing spondylitis patients with elevated C-reactive protein levels may experience greater benefits from treatment with the interleukin-17A inhibitor secukinumab than those with lower levels of the inflammatory marker, researchers report.

Source:

RMD Open 2018; 4: e000749

Meet our Editorial Board

New Content Item Meet our Advisory Board

image credits